Cargando…
Metabolic pathway engineering using the central signal processor P(II)
BACKGROUND: P(II) signal processor proteins are wide spread in prokaryotes and plants where they control a multitude of anabolic reactions. Efficient overproduction of metabolites requires relaxing the tight cellular control circuits. Here we demonstrate that a single point mutation in the P(II) sig...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660640/ https://www.ncbi.nlm.nih.gov/pubmed/26608263 http://dx.doi.org/10.1186/s12934-015-0384-4 |
_version_ | 1782402842200375296 |
---|---|
author | Watzer, Björn Engelbrecht, Alicia Hauf, Waldemar Stahl, Mark Maldener, Iris Forchhammer, Karl |
author_facet | Watzer, Björn Engelbrecht, Alicia Hauf, Waldemar Stahl, Mark Maldener, Iris Forchhammer, Karl |
author_sort | Watzer, Björn |
collection | PubMed |
description | BACKGROUND: P(II) signal processor proteins are wide spread in prokaryotes and plants where they control a multitude of anabolic reactions. Efficient overproduction of metabolites requires relaxing the tight cellular control circuits. Here we demonstrate that a single point mutation in the P(II) signaling protein from the cyanobacterium Synechocystis sp. PCC 6803 is sufficient to unlock the arginine pathway causing over accumulation of the biopolymer cyanophycin (multi-l-arginyl-poly-l-aspartate). This product is of biotechnological interest as a source of amino acids and polyaspartic acid. This work exemplifies a novel approach of pathway engineering by designing custom-tailored P(II) signaling proteins. Here, the engineered Synechocystis sp. PCC6803 strain with a P(II)-I86N mutation over-accumulated arginine through constitutive activation of the key enzyme N-acetylglutamate kinase (NAGK). RESULTS: In the engineered strain BW86, in vivo NAGK activity was strongly increased and led to a more than tenfold higher arginine content than in the wild-type. As a consequence, strain BW86 accumulated up to 57 % cyanophycin per cell dry mass under the tested conditions, which is the highest yield of cyanophycin reported to date. Strain BW86 produced cyanophycin in a molecular mass range of 25 to >100 kDa; the wild-type produced the polymer in a range of 30 to >100 kDa. CONCLUSIONS: The high yield and high molecular mass of cyanophycin produced by strain BW86 along with the low nutrient requirements of cyanobacteria make it a promising means for the biotechnological production of cyanophycin. This study furthermore demonstrates the feasibility of metabolic pathway engineering using the P(II) signaling protein, which occurs in numerous bacterial species. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0384-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4660640 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46606402015-11-27 Metabolic pathway engineering using the central signal processor P(II) Watzer, Björn Engelbrecht, Alicia Hauf, Waldemar Stahl, Mark Maldener, Iris Forchhammer, Karl Microb Cell Fact Research BACKGROUND: P(II) signal processor proteins are wide spread in prokaryotes and plants where they control a multitude of anabolic reactions. Efficient overproduction of metabolites requires relaxing the tight cellular control circuits. Here we demonstrate that a single point mutation in the P(II) signaling protein from the cyanobacterium Synechocystis sp. PCC 6803 is sufficient to unlock the arginine pathway causing over accumulation of the biopolymer cyanophycin (multi-l-arginyl-poly-l-aspartate). This product is of biotechnological interest as a source of amino acids and polyaspartic acid. This work exemplifies a novel approach of pathway engineering by designing custom-tailored P(II) signaling proteins. Here, the engineered Synechocystis sp. PCC6803 strain with a P(II)-I86N mutation over-accumulated arginine through constitutive activation of the key enzyme N-acetylglutamate kinase (NAGK). RESULTS: In the engineered strain BW86, in vivo NAGK activity was strongly increased and led to a more than tenfold higher arginine content than in the wild-type. As a consequence, strain BW86 accumulated up to 57 % cyanophycin per cell dry mass under the tested conditions, which is the highest yield of cyanophycin reported to date. Strain BW86 produced cyanophycin in a molecular mass range of 25 to >100 kDa; the wild-type produced the polymer in a range of 30 to >100 kDa. CONCLUSIONS: The high yield and high molecular mass of cyanophycin produced by strain BW86 along with the low nutrient requirements of cyanobacteria make it a promising means for the biotechnological production of cyanophycin. This study furthermore demonstrates the feasibility of metabolic pathway engineering using the P(II) signaling protein, which occurs in numerous bacterial species. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0384-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-25 /pmc/articles/PMC4660640/ /pubmed/26608263 http://dx.doi.org/10.1186/s12934-015-0384-4 Text en © Watzer et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Watzer, Björn Engelbrecht, Alicia Hauf, Waldemar Stahl, Mark Maldener, Iris Forchhammer, Karl Metabolic pathway engineering using the central signal processor P(II) |
title | Metabolic pathway engineering using the central signal processor P(II) |
title_full | Metabolic pathway engineering using the central signal processor P(II) |
title_fullStr | Metabolic pathway engineering using the central signal processor P(II) |
title_full_unstemmed | Metabolic pathway engineering using the central signal processor P(II) |
title_short | Metabolic pathway engineering using the central signal processor P(II) |
title_sort | metabolic pathway engineering using the central signal processor p(ii) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660640/ https://www.ncbi.nlm.nih.gov/pubmed/26608263 http://dx.doi.org/10.1186/s12934-015-0384-4 |
work_keys_str_mv | AT watzerbjorn metabolicpathwayengineeringusingthecentralsignalprocessorpii AT engelbrechtalicia metabolicpathwayengineeringusingthecentralsignalprocessorpii AT haufwaldemar metabolicpathwayengineeringusingthecentralsignalprocessorpii AT stahlmark metabolicpathwayengineeringusingthecentralsignalprocessorpii AT maldeneriris metabolicpathwayengineeringusingthecentralsignalprocessorpii AT forchhammerkarl metabolicpathwayengineeringusingthecentralsignalprocessorpii |